

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
– SAFE Banking Act would provide cannabis companies access to banking services that all other legal businesses have- American cannabis companies would be on more equal footing with Canadian cannabis peers with access to depository […]
DENVER, Dec. 11, 2018 — US-based Elixinol (OTC: ELLXF) announces the distribution of its first globally available, all-natural, hemp-based skin care and hair care line, Sativa. Get our FREE Newsletter! Discover Stocks with +1,000% Upside […]
Nigam Arora: The Coming “Canadian Marijuana Stocks Massacre”. Nigam discusses his long term outlook for cannabis stocks… He expects cannabis stocks focused on the Canadian market to lose 90% value, as market realities set in. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.